P3 Health Partners Inc. Reaffirmed Earnings Guidance for the full-year ending December 31, 2024. For the year, the company Reaffirming revenue from $1.45 billion to $1.55 billion.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5461 USD | -6.15% | +12.07% | -61.27% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-61.27% | 65.32M | |
+55.55% | 59.28B | |
+43.62% | 40.94B | |
-4.71% | 40.17B | |
-5.56% | 28.69B | |
+13.76% | 26.63B | |
-22.00% | 18.89B | |
+31.50% | 12.46B | |
+2.16% | 12.42B | |
+25.70% | 12.26B |
- Stock Market
- Equities
- PIII Stock
- News P3 Health Partners Inc.
- P3 Health Partners Inc. Reaffirms Earnings Guidance for the full-year ending December 31, 2024